Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction

American Journal of Cardiology

Volumn 94, Issue 11, 2004, Pages 1406-1410

  Turakhia, Minang P ^b   Murphy, Sabina A ^a   Pinto, Tina L ^c   Antman, Elliott M ^a   Giugliano, Robert P ^d   Cannon, Christopher P ^a   Braunwald, Eugene ^a   Gibson, C Michael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; ANISTREPLASE; C REACTIVE PROTEIN; CREATINE KINASE; ENOXAPARIN; EPTIFIBATIDE; FIBRINOLYTIC AGENT; HEPARIN; RECOMBINANT PLASMINOGEN ACTIVATOR; STREPTOKINASE; TENECTEPLASE; TIROFIBAN;

ACUTE HEART INFARCTION; AGE DISTRIBUTION; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DOSE RESPONSE; FIBRINOLYTIC THERAPY; HUMAN; LOW DRUG DOSE; META ANALYSIS; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; TREATMENT OUTCOME;

AGED; CLINICAL TRIALS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET COUNT; RISK FACTORS; THROMBOSIS;

EID: 9344248036     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.08.015     Document Type: Article

References (20)

1. C.P. Cannon, C.H. McCabe, D.J. Diver, S. Herson, R.M. Greene, P.K. Shah, R.F. Sequeira, F. Leya, J.M. Kirshenbaum, R.D. Magorien Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial J Am Coll Cardiol 24 1994 1602 1610
2. C.P. Cannon, C.H. McCabe, C.M. Gibson, M. Ghali, R.F. Sequeira, G.R. McKendall, J. Breed, N.B. Modi, N.L. Fox, R.P. Tracy TNK-tissue plasminogen activator in acute myocardial infarction Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial Circulation 95 1997 351 356
3. C.P. Cannon, C.M. Gibson, C.H. McCabe, A.A. Adgey, M.J. Schweiger, R.F. Sequeira, G. Grollier, R.P. Giugliano, M. Frey, H.S. Mueller TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators Circulation 98 1998 2805 2814
4. E.M. Antman, R.P. Giugliano, C.M. Gibson, C.H. McCabe, P. Coussement, N.S. Kleiman, A. Vahanian, A.A. Adgey, I. Menown, H.J. Rupprecht Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial The TIMI 14 Investigators Circulation 99 1999 2720 2732
5. Giugliano RP, Roe MT, Harrington RA, Gibson CM, Zeymer U, Van de Werf F, Baran KW, Hobbach HP, Woodlief LH, Hannan KL, et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST elevation myocardial infarction: results of the Integrilin and Tenecteplase in Acute Myocardial Infarction (INTEGRITI) phase II angiographic trial. J Am Coll Cardiol 2003;41:1251-1260.
6. E.M. Antman, H.W. Louwerenburg, H.F. Baars, J.C. Wesdorp, B. Hamer, J.P. Bassand, F. Bigonzi, G. Pisapia, C.M. Gibson, H. Heidbuchel Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation 105 2002 1642 1649
7. TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial Phase I findings N Engl J Med 312 1985 932 936
8. C.M. Gibson, S.A. Murphy, M.J. Rizzo, K.A. Ryan, S.J. Marble, C.H. McCabe, C.P. Cannon, F. Van de Werf, E. Braunwald Relationship between TIMI frame count and clinical outcomes after thrombolytic administration Thrombolysis In Myocardial Infarction (TIMI) Study Group Circulation 99 1999 1945 1950
9. C.M. Gibson, C.P. Cannon, S.A. Murphy, K.A. Ryan, R. Mesley, S.J. Marble, C.H. McCabe, F. Van De Werf, E. Braunwald Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 101 2000 125 130
10. C.M. Gibson, J.A. de Lemos, S.A. Murphy, S.J. Marble, C.H. McCabe, C.P. Cannon, E.M. Antman, E. Braunwald Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation 103 2001 2550 2554
11. StataCorp Stata Statistical Software 2000 Stata Corporation College Station, TX
12. D.J. Fitzgerald, F. Catella, L. Roy, G.A. FitzGerald Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction Circulation 77 1988 142 150
13. E. Posan, G. Ujj, A. Kiss, B. Telek, K. Rak, M. Udvardy Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia Thromb Res 90 1998 51 56
14. M. Bazzan, G. Tamponi, E. Gallo, S. Stella, P.C. Schinco, A. Pannocchia, A. Pileri Fibrinolytic imbalance in essential thrombocythemia: role of platelets Haemostasis 23 1993 38 44
15. C.M. Gibson, D.A. Morrow, R. Vicari, G.C. Wong, L.A. Demopoulos, P. DiBattiste, S. Murphy, C.P. Cannon, E. Braunwald Elevated C reactive protein (CRP) is associated with a higher risk of thrombotic occlusion and poorer flow following percutaneous coronary intervention in patients with acute coronary syndromes: a TACTICS-TIMI 18 angiographic substudy J Am Coll Cardiol 39 suppl A 2002 304A
16. H.V. Barron, C.P. Cannon, S.A. Murphy, E. Braunwald, C.M. Gibson Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy Circulation 102 2000 2329 2334
17. G. Rousseau, D. Hebert, D. Libersan, A. Khalil, G. St-Jean, J.G. Latour Importance of platelets in myocardial injury after reperfusion in the presence of residual coronary stenosis in dogs Am Heart J 125 1993 1553 1563
18. L. Pizzulli, A. Yang, J.F. Martin Changes in platelet size and count in unstable angina compared to stable angina or non cardiac chest pain Eur Heart J 19 1998 80 84
19. C.M. Gibson, S. Murphy, I.B. Menown, R.F. Sequeira, R. Greene, F. Van de Werf, M.J. Schweiger, M. Ghali, M.J. Frey, K.A. Ryan Determinants of coronary blood flow after thrombolytic administration TIMI Study Group. Thrombolysis in Myocardial Infarction J Am Coll Cardiol 34 1999 1403 1412
20. C.K. Wong, J.K. French, W. Gao, H.D. White Relation of initial platelet counts to Thrombolysis In Myocardial Infarction-3 flow rates at 90 minutes after commencing fibrinolytic therapy in patients with acute myocardial infarction Am J Cardiol 90 2002 54 57